Crowdonomics
WatchlistPortfolio
All companies
SUNNY logo

SUNNY

Operating

Menstrual Mates, Inc.

Healthcare · Founded 2021

Visit website

Ingenious period cup and applicator that is a 'total game changer for period care'

Valuation cap ⓘ
$7.0M
As of Nov 2025 · from Reg CF Offering (2024) · a SAFE/note conversion ceiling, not a priced valuation
Total raised
$61,050
Across 2 rounds since 2023

Financials

FY2021–FY2025 · from SEC filings · hover any figure for its source
$627
−$60K
2021
$2K
−$455K
2022
$118K
−$1.1M
2023
$2K
−$455K
2024
$118K
−$1.1M
2025
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2021 unaudited
FY2022 unaudited
FY2023 unaudited
FY2024 unaudited
FY2025 unaudited
Income statement
Revenue
$627
$2,131
$117,809
$2,131
$117,809
Cost of goods sold
$542
$1,407
$44,266
$1,407
$44,266
Gross margin
14%
34%
62%
34%
62%
Net income
-$59,839
-$454,992
-$1,088,064
-$454,992
-$1,088,064
Taxes paid
$0
$8,932
$36,255
$8,932
$36,255
Balance sheet
Cash
$101,757
$1,207,853
$65,295
$1,207,853
$65,295
Accounts receivable
$0
$0
$0
$0
$0
Total assets
$102,368
$1,676,229
$1,452,162
$1,676,229
$1,452,162
Short-term debt
$857
$560,955
$825,448
$560,955
$825,448
Long-term debt
$70,000
$1,538,755
$2,138,259
$1,538,755
$2,138,259
Total liabilities
$70,857
$2,099,710
$2,963,707
$2,099,710
$2,963,707
Other
Headcount
—
5
2
—
2

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Valuation caps on SAFE / convertible note rounds
$7.0M
Valuation cap
$7.0M
Valuation cap
Reg CF · Note · Sep 2023
Reg CF · Note · Jul 2024

Dashed amber bars are a SAFE or convertible note's valuation cap — the most it converts at, not what the company is worth.

Fundraising history

Reg CF · Convertible Note · Jul 2024Closedvia WeFunder
Raised $0 / $63.2KValuation cap $7M
Reg CF · Convertible Note · Sep 2023Closedvia WeFunder
Raised $61.1K / $124KInvestors 19Valuation cap $7M

Team

3 people
Cindy BelardoFounder
CEO + Co-Founder
Drew JarvisFounder
CMO + Co-Founder
Patrick Henshaw
Managing Director

Names and titles as disclosed on SEC Form C. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not requiredFewer than 300 holders of record

Filed 2 of 3 annual reports (FY2023–FY2025)

19 investors
holder-count proxy

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C-ARMay 11, 20260001990587-26-000001
    EDGAR
  • Form C/AApr 15, 20250001670254-25-000364
    EDGAR
  • Form C/AJul 10, 20240001670254-24-000752
    EDGAR
  • Form CJul 3, 20240001670254-24-000747
    EDGAR
  • Form C-ARJun 13, 20240001670254-24-000696
    EDGAR
  • Form CAug 25, 20230001670254-23-000816
    EDGAR
Source: ManualCIK 0001990587

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.